Nervonik completed a first-in-human feasibility study demonstrating nerve sensing during peripheral nerve stimulation. The system captured evoked compound action potentials and muscle potentials during active stimulation, markers the company intends to use for future biosensing-enabled features such as closed-loop therapy.